Dubai chocolate spread recalled in US; FDA issues highest risk warning
World Market has recalled the product named Emek Spread Pistachio Cacao Cream with Kadayif due to a potential contamination of salmonella, the announcement on the FDA's site read. The products were distributed between June 11 to July 9, 2025.
The recall of the Emek products was first initiated on July 14. Three days later, the FDA updated it to a Class I classification, Newsweek reported.
"Salmonella is an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Healthy persons infected with Salmonella often experience fever, diarrhea (which may be bloody), nausea, vomiting and abdominal pain," the statement said.
Stay up to date with the latest news. Follow KT on WhatsApp Channels.
"In rare circumstances, infection with Salmonella can result in the organism getting into the bloodstream and producing more severe illnesses such as arterial infections (i.e., infected aneurysms), endocarditis and arthritis," it added.
The firm initiated the recall after samples of the product were tested by the FDA and the products tested positive for Salmonella. However, no illnesses have been reported to date.
The 'Dubai chocolate', a chocolate bar containing a pistachio and kunafa filling, became popular after going viral on TikTok in 2024. The original chocolate bar was created by Fix Dessert Chocolatier in Dubai, but variations have been made by several brands, including Emek Gıda, whose product is the one affected by the current recall.
FIX Dessert Chocolatier, a Dubai-based dessert brand founded by Sarah Hamouda, came up with the idea of the pistachio kunafa bar. Chef Nouel Catis, a Filipino dessert specialist, was hired by FIX to help develop the now-viral pistachio kunafa chocolate.
Last month, British regulator Food Standards Agency (FSA) said that some Dubai style chocolate being sold in the UK retail market may not meet the country's criteria and may contain banned additives or colouring agents.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Zawya
9 hours ago
- Zawya
FDA to appoint George Tidmarsh as top drug regulator
U.S. Food and Drug Administration commissioner Marty Makary has chosen former biotech executive George Tidmarsh as the director of the Center for Drug Evaluation and Research, Bloomberg News reported on Monday, citing a person familiar with the decision. Tidmarsh's appointment as the agency's top drug regulator could be announced as soon as Monday, the report said, citing the person who asked not to be identified. Jacqueline Corrigan-Curay, the acting head of the division, recently announced she was leaving the agency, according to the report. The Department of Health and Human Services, which oversees the FDA, did not immediately respond to a Reuters request for comment. Tidmarsh also did not immediately respond to email and LinkedIn requests for comment. Tidmarsh, a Stanford University-affiliated pediatrician, will oversee one of the FDA's largest and most important divisions, which regulates over-the-counter and prescription drugs, including biological therapeutics and generic drugs. In May, he took part in an FDA expert panel to discuss the safety and necessity of talc as an additive in food, drug and cosmetic products. "It's not if talc should be removed from the U.S. market. It's a matter of how and when. It's a dangerous substance. We have safer, more modern low cost alternatives," Tidmarsh had then said. He previously served as the chief executive officer of Horizon Pharma — a company he founded in 2005. While at Horizon, he led all aspects of development of Duexis, which was approved by the FDA for the treatment of rheumatoid arthritis. Tidmarsh also held senior positions at other biotechs such as SEQUUS Pharmaceuticals and Coulter Pharmaceutical. He retired from Revelation Biosciences' board in May. (Reporting by Sriparna Roy and Sneha S K in Bengaluru; Editing by Shilpi Majumdar)
Khaleej Times
10 hours ago
- Khaleej Times
Mediclinic City Hospital and Mediclinic Parkview Hospital achieve Center of Excellence Accreditation in Endoscopy
The recognition reflects the hospitals' unwavering commitment to delivering world-class patient care, advanced medical expertise, and excellence in endoscopic procedures Mediclinic Middle East is proud to announce that both Mediclinic City Hospital and Mediclinic Parkview Hospital have been recognised as Centres of Excellence (COE) in Endoscopy by the Surgical Review Corporation (SRC). This international recognition reflects the hospitals' unwavering commitment to delivering world-class patient care, advanced medical expertise, and excellence in endoscopic procedures. The COE accreditation is granted to healthcare institutions that meet rigourous standards in patient safety, clinical quality, and innovative practices in endoscopy. It highlights highly trained specialists, state-of-the-art technology, and a continuous dedication to improving patient outcomes. "We are honoured to receive this designation for two of our facilities, it underscores our dedication to providing the highest standards of endoscopic care," said Dr Jacques Kobersy, chief medical officer, Mediclinic Middle East. "This achievement reflects the expertise of our medical teams and our commitment to patient safety, precision diagnostics, and cutting-edge treatment options." Endoscopic procedures play a crucial role in diagnosing and treating a wide range of medical conditions with minimally invasive techniques that promote faster recovery and improved patient experiences. The SRC accreditation assures patients that Mediclinic City Hospital and Mediclinic Parkview Hospital adhere to the highest levels of excellence in this field.
Zawya
10 hours ago
- Zawya
Dubai Health Authority welcomes 20 global health leaders
The Dubai Health Authority (DHA) has welcomed a delegation of 20 senior healthcare leaders from various countries around the world, as part of its participation in the International Programme for Health Leadership. The programme is organised by the Government Experience Exchange Office (GEEO), under the Ministry of Cabinet Affairs, to exchange global best practices in healthcare and strengthen institutional knowledge partnerships. The delegation was introduced to Dubai's pioneering experience in advancing the healthcare sector and the significant achievements made in sustainability and the quality of care, reflecting the emirate's elevated global standing in public health and quality of life indices. During the meeting, DHA teams presented key aspects of the institutional transformation currently underway within Dubai's healthcare system, along with the emirate's health sector strategy. The session also covered the public health protection framework and the mechanisms for prevention and epidemic response. A detailed presentation was delivered outlining the authority's efforts to promote community health, strengthen preventive readiness, and ensure the integration of legislative and regulatory infrastructure in this domain. The teams also showcased the healthcare regulatory frameworks adopted in Dubai, along with the advanced standards and policies that reflect the authority's strategic approach and future vision for regulating healthcare professions and facilities across the emirate. The presentation further highlighted the integrated health insurance system and the sustainable financing mechanisms that contribute to the continuity and financial efficiency of healthcare services. The meeting also featured a specialised presentation on the findings of Dubai's Household Health Survey, emphasising the critical role of accurate data in supporting decision-making and enhancing planning based on scientific research and analytical insights. The delegation also undertook a field visit to the Dubai Health Authority's Crisis and Disaster Management Centre, where they received a detailed briefing on the emirate's emergency health management system. The session highlighted DHA's efforts to ensure maximum responsiveness during crises and disasters, as well as the centre's advanced capabilities. Dr. Alawi AlSheikh-Ali, Director-General of DHA, affirmed that the rapid progress in Dubai's healthcare sector has played a key role in reinforcing the emirate's position as a global leader in quality of life and healthcare.
